Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activity
- 1 June 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 38 (6) , 452-459
- https://doi.org/10.1111/j.2042-7158.1986.tb04609.x
Abstract
The pharmacological properties of SK&F 94120 on the cardiovascular system have been studied in laboratory animal species. The compound was shown to have positive inotropic activity on hearts from guinea-pig, cat, dog and marmoset in-vitro and in cat and dog in-vivo. These responses in-vivo occurred in association with minimal changes in heart rate. Positive inotropic activity was not caused by SK&F 94120 in rat or hamster hearts in-vitro, thereby indicating a species dependence in myocardial response. SK&F 94120 was shown to have vasodilator activity in cats in-vivo. Detailed studies carried out on anaesthetized cats indicated that the compound caused a balanced dilatation of both resistance and capacitance blood vessels. Haemodynamic studies in anaesthetized cats indicated that, as a consequence of the positive inotropic and vasodilator actions, SK&F 94120 causes significant increases in cardiac output and stroke volume. Studies in conscious dogs showed the compound to be active as a positive inotrope after oral administration. The above properties suggest that this compound possesses useful haemodynamic properties for the treatment of congestive heart failure.This publication has 3 references indexed in Scilit:
- Evidence that oxmetidine inhibits transmembrane calcium flux in cardiac and vascular tissueBritish Journal of Pharmacology, 1985
- Hemodynamic Profile of a New Antihypertensive Agent D,L-3-[2-(3-t-Butylamino-2-hydroxy-propoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657)Journal of Cardiovascular Pharmacology, 1981
- Characterization of an isolated, working guinea-pig heart including effects of histamine and noradrenalineJournal of Pharmacological Methods, 1978